Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Nebulized Sodium Nitrite (AIR001) Following Repeat-Dose Inhalation in Healthy Subjects by Rix, Peter J., Vick, Andrew, Attkins, Neil J., Barker, Geoffrey E., Bott, Adrian W., Alcorn, Harry, Gladwin, Mark T., Shiva, Sruti, Bradley, Stephen, Hussaini, Azra, Hoye, William L., Parsley, Ed L., Masamune, Hiroko

Get full text

Acute hemodynamic effects of inhaled sodium nitrite in pulmonary hypertension associated with heart failure with preserved ejection fraction by Simon, Marc A, Vanderpool, Rebecca R, Nouraie, Mehdi, Bachman, Timothy N, White, Pamela M, Sugahara, Masataka, Gorcsan, 3rd, John, Parsley, Ed L, Gladwin, Mark T

Get full text

P66: Nebulized inhaled nitrite (AIR001) for pulmonary arterial hypertension: Studies to determine safety, pharmacokinetics, and maximum tolerated dose, lack of pharmacodynamic inte... by Parsley, Ed L., Masamune, Hiroko, Hoye, Will L., Rubin, Lewis J., Gladwin, Mark T.

Get full text

P66 by Parsley, Ed L., Masamune, Hiroko, Hoye, Will L., Rubin, Lewis J., Gladwin, Mark T.

Get full text

Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease by Tashkin, Donald P, Elashoff, Robert, Clements, Philip J, Roth, Michael D, Furst, Daniel E, Silver, Richard M, Goldin, Jonathan, Arriola, Edgar, Strange, Charlie, Bolster, Marcy B, Seibold, James R, Riley, David J, Hsu, Vivien M, Varga, John, Schraufnagel, Dean, Theodore, Arthur, Simms, Robert, Wise, Robert, Wigley, Fred, White, Barbara, Steen, Virginia, Read, Charles, Mayes, Maureen, Parsley, Ed, Mubarak, Kamal, Connolly, M. Kari, Golden, Jeffrey, Olman, Mitchell, Fessler, Barri, Rothfield, Naomi, Metersky, Mark, Khanna, Dinesh, Li, Ning, Li, Gang, Scleroderma Lung Study Research Group

Get full text

Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial by Casella, James F, Barton, Bruce A, Kanter, Julie, Black, L. Vandy, Majumdar, Suvankar, Inati, Adlette, Wali, Yasser, Drachtman, Richard A, Abboud, Miguel R, Kilinc, Yurdanur, Fuh, Beng R, Al-Khabori, Murtadha K, Takemoto, Clifford M, Salman, Emad, Sarnaik, Sharada A, Shah, Nirmish, Morris, Claudia R, Keates-Baleeiro, Jennifer, Raj, Ashok, Alvarez, Ofelia A, Hsu, Lewis L, Thompson, Alexis A, Sisler, India Y, Pace, Betty S, Noronha, Suzie A, Lasky, Joseph L, de Julian, Elena Cela, Godder, Kamar, Thornburg, Courtney Dawn, Kamberos, Natalie L, Nuss, Rachelle, Marsh, Anne M, Owen, William C, Schaefer, Anne, Tebbi, Cameron K, Chantrain, Christophe F, Cohen, Debra E, Karakas, Zeynep, Piccone, Connie M, George, Alex, Fixler, Jason M, Singleton, Tammuella C, Moulton, Thomas, Quinn, Charles T, de Castro Lobo, Clarisse Lopes, Almomen, Abdulkareem M, Goyal-Khemka, Meenakshi, Maes, Philip, Emanuele, Marty, Gorney, Rebecca T, Padgett, Claire S, Parsley, Ed, Kronsberg, Shari S, Kato, Gregory J, Gladwin, Mark T

Get full text

Predicting treatment outcomes and responder subsets in scleroderma‐related interstitial lung disease by Roth, Michael D., Tseng, Chi‐Hong, Clements, Philip J., Furst, Daniel E., Tashkin, Donald P., Goldin, Jonathan G., Khanna, Dinesh, Kleerup, Eric C., Li, Ning, Elashoff, David, Elashoff, Robert M.

Get full text

Bronchoalveolar Lavage and Response to Cyclophosphamide in Scleroderma Interstitial Lung Disease by Strange, Charlie, Bolster, Marcy B, Roth, Michael D, Silver, Richard M, Theodore, Arthur, Goldin, Jonathan, Clements, Philip, Chung, Joanie, Elashoff, Robert M, Suh, Robert, Smith, Edwin A, Furst, Daniel E, Tashkin, Donald P, Scleroderma Lung Study Research Group

Get full text